OFICINA REGIONAL DE ONUSIDA PARA AMÉRICA LATINA Y EL CARIBE

Guatemala


CONTACTO

Ricardo García Bernal

Director de país de ONUSIDA

+50223818610

Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.


Datos de país 2016


Adults and children living with HIV46 000 [31 000 - 65 000]
Adults aged 15 and over living with HIV44 000 [30 000 - 62 000]
Women aged 15 and over living with HIV18 000 [12 000 - 25 000]
Men aged 15 and over living with HIV27 000 [18 000 - 38 000]
Children aged 0 to 14 living with HIV1800 [1200 - 2600]
Adult aged 15 to 49 HIV prevalence rate0.5 [0.3 - 0.7]
Women aged 15 to 49 HIV prevalence rate0.4 [0.2 - 0.5]
Men aged 15 to 49 HIV prevalence rate0.6 [0.4 - 0.8]
HIV prevalence among young women0.2 [<0.1 - 0.3]
HIV prevalence among young men0.2 [<0.1 - 0.4]
Adults and children newly infected with HIV2900 [1400 - 5200]
Adults aged 15 and over newly infected with HIV2600 [1200 - 4700]
Women aged 15 and over newly infected with HIV1100 [<1000 - 2100]
Men aged 15 and over newly infected with HIV1400 [<1000 - 2600]
Children aged 0 to 14 newly infected with HIV<500 [<200 - <500]
HIV incidence per 1000 population (adults 15-49)0.30 [0.15 - 0.55]
HIV incidence per 1000 population (all ages)0.18 [0.09 - 0.32]
Adult and child deaths due to AIDS1600 [<1000 - 2800]
Deaths due to AIDS among adults aged 15 and over1400 [<1000 - 2500]
Deaths due to AIDS among women aged 15 and over<500 [<500 - <1000]
Deaths due to AIDS among men aged 15 and over1000 [<1000 - 1700]
Deaths due to AIDS among children aged 0 to 14 <200 [<100 - <500]
Orphans due to AIDS aged 0 to 1711 000 [5500 - 18 000]

Adults and children living with HIV46 000 [31 000 - 65 000]
Adults aged 15 and over living with HIV44 000 [30 000 - 62 000]
Women aged 15 and over living with HIV18 000 [12 000 - 25 000]
Men aged 15 and over living with HIV27 000 [18 000 - 38 000]
Children aged 0 to 14 living with HIV1800 [1200 - 2600]
Adult aged 15 to 49 HIV prevalence rate0.5 [0.3 - 0.7]
Women aged 15 to 49 HIV prevalence rate0.4 [0.2 - 0.5]
Men aged 15 to 49 HIV prevalence rate0.6 [0.4 - 0.8]
HIV prevalence among young women0.2 [<0.1 - 0.3]
HIV prevalence among young men0.2 [<0.1 - 0.4]
Adults and children newly infected with HIV2900 [1400 - 5200]
Adults aged 15 and over newly infected with HIV2600 [1200 - 4700]
Women aged 15 and over newly infected with HIV1100 [<1000 - 2100]
Men aged 15 and over newly infected with HIV1400 [<1000 - 2600]
Children aged 0 to 14 newly infected with HIV<500 [<200 - <500]
HIV incidence per 1000 population (adults 15-49)0.30 [0.15 - 0.55]
HIV incidence per 1000 population (all ages)0.18 [0.09 - 0.32]
Adult and child deaths due to AIDS1600 [<1000 - 2800]
Deaths due to AIDS among adults aged 15 and over1400 [<1000 - 2500]
Deaths due to AIDS among women aged 15 and over<500 [<500 - <1000]
Deaths due to AIDS among men aged 15 and over1000 [<1000 - 1700]
Deaths due to AIDS among children aged 0 to 14 <200 [<100 - <500]
Orphans due to AIDS aged 0 to 1711 000 [5500 - 18 000]

Coverage of adults and children receiving ART (%)36 [24 - 50]
Adults aged 15 and over receiving ART36 [24 - 50]
Women aged 15 and over receiving ART37 [24 - 53]
Men aged 15 and over receiving ART35 [23 - 49]
Children aged 0 to 14 receiving ART42 [29 - 61]
Number of adults and children receiving ART (#)16 600
Adults aged 15 and over receiving ART15 900
Women aged 15 and over receiving ART6500
Men aged 15 and over receiving ART9400
Children aged 0 to 14 receiving ART760
Late HIV diagnosis [with the initial CD4 cell count <200 cells/ mm3] (%)48
Late HIV diagnosis among adults aged 15 and over50
Late HIV diagnosis among women48
Late HIV diagnosis among men48
Adults and children newly-initiating ART (#)1561
Adults aged 15 and over newly-initiating ART1489
Children aged 0-14 newly-initiating ART72
Women newly-initiating ART458
Men newly-initiating ART1103
Adults and children known to be on ART 12 months after starting (%)75
Adults known to be on ART 12 months after starting75
Children known to be on ART 12 months after starting53

Coverage of pregnant women who receive ARV for PMTCT (%)19 [13 - 28]
Pregnant women who received ARV for PMTCT (#)240
Pregnant women needing ARV for PMTCT (#)1200 [<1000 - 1800]
Early infant diagnosis (%)15 [10 - 22]
New HIV infections averted due to PMTCT (%)<100 [<100 - <200]

Population size estimate (#)25 846 Year of estimation: 2010; Quetzaltenango, Mazatenango, Escuintla, Guatemala, Coban
HIV prevalence (%)1.6 Source: Medición de Prevalencia, Comportamiento, Actitudes y Prácticas en poblaciones de mayor riesgo al VIH-Sida en Guatemala, 2017.
Condom use (%)97.7 Source: Encuesta de Centroamericana de comportamiento Sexual y Prevalencia de VIH/ITS en poblaciones Vulnerables (ECVC) En Hombres que tiene sexo con Hombres , Población trangenero, Trabajadoras Sexuales y Personas con VIH

Population size estimate (#)104 876 Year of estimation: 2010; Guatemala, Quetzaltenango, Mazatenango, Escuintla, Coban
HIV prevalence (%)8 Source: Datos preliminares del estudio de Medición de Prevalencia, Comportamiento, Actitudes y Prácticas en poblaciones de mayor riesgo al VIH-Sida en Guatemala, 2017.
Condom use (%)63.3 Source: Encuesta de Centroamericana de comportamiento Sexual y Prevalencia de VIH/ITS en poblaciones Vulnerables (ECVC) En Hombres que tiene sexo con Hombres , Población trangenero, Trabajadoras Sexuales y Personas con VIH

HIV prevalence (%)0.7 Source: Encuesta Centroamericana de Vigilancia de Comportamiento Sexual y Prevalencia del VIH e ITS en poblaciones vulnerables y en poblaciones clave (ECVC), 2012-2013
HIV prevention programmes in prisons: condoms distributed (#)72 706 Source: Base de datos SIGPRO de Hivos y registros de Sistema Penitenciario, 2016

Population size estimate (#)4840 Year of Estimation: 2015; Quetzaltenango, Escuintla, Suchitapeque, Izabal, Guatemala
HIV prevalence (%)22.2 Source: Datos preliminares del estudio de Medición de Prevalencia, Comportamiento, Actitudes y Prácticas en poblaciones de mayor riesgo al VIH-Sida en Guatemala, 2017.

Population size estimate (#)4840 Year of Estimation: 2015; Quetzaltenango, Escuintla, Suchitapeque, Izabal, Guatemala
HIV prevalence (%)22.2 Source: Datos preliminares del estudio de Medición de Prevalencia, Comportamiento, Actitudes y Prácticas en poblaciones de mayor riesgo al VIH-Sida en Guatemala, 2017.

Percentage of adults (15-49) who responded No to the question: Would you buy fresh vegetables from a shopkeeper or vendor if you knew that this person had HIV?60.6 Source: Encuesta Nacional de Salud Materno Infantil 2008-09
Percentage of adults (15-49) who responded No to the question: Do you think that children living with HIV should be able to attend school with children who are HIV negative?
Percentage of adults (15-49) who responded No to both questions

Prevalence of recent intimate partner violence among women aged 15-49 (%)8.5 Source: ENSMI 2014-2015
Prevalence of recent intimate partner violence among women aged 15-19 (%)8.8 Source: ENSMI 2014-2015
Prevalence of recent intimate partner violence among women aged 20-24 (%)11.4 Source: ENSMI 2014-2015
Prevalence of recent intimate partner violence among women aged 25-49 (%)7.9 Source: ENSMI 2014-2015
Women aged 15-49 who have their demand for family planning satisfied by modern methods (%)65.6 Refers to currently married women only; Source: ENSMI 2014-2015
Women aged 15-19 who have their demand for family planning satisfied by modern methods (%)50.4 Refers to currently married women only; Source: ENSMI 2014-2015
Women aged 20-24 who have their demand for family planning satisfied by modern methods (%)58.8 Refers to currently married women only; Source: ENSMI 2014-2015
Women aged 25-49 who have their demand for family planning satisfied by modern methods (%)

Knowledge about HIV prevention among young people aged 15-2422.12 Source: 2014-15 DHIS
Knowledge about HIV prevention among young women aged 15-2422.21 Source: 2014-15 DHIS
Knowledge about HIV prevention among young men aged 15-2421.9 Source: 2014-15 DHIS

Total country-reported HIV expenditure (USD)50 500 000 GAM 2017 validated records
HIV expenditure from domestic public sources (USD)32 500 000 GAM 2017 validated records
HIV expenditure from domestic private sources (USD)2 500 000 GAM 2017 validated records
HIV expenditure from international sources (USD)15 400 000 GAM 2017 validated records

Co-management of TB and HIV treatment (%)68 [48 - >95]
Proportion of people living with HIV newly enrolled in HIV care with active TB disease (%)5
Proportion of people living with HIV newly enrolled in HIV care started on TB preventive therapy (%)3
Estimated TB-related deaths among people living with HIV (#)<100 [<100 - <100]

 

 

 

 

back to top
CONÉCTATE CON NOSOTROS

Estamos en las redes sociales.

Síguenos

Arrow
Arrow
Slider
CONTÁCTANOS

Ciudad del Saber, calle Gonzalo Crance, Edificio #166. Apartado Postal: 0816-01914, Ciudad de Panamá, Panamá.

Tel. +507 3014600

Arrow
Arrow
Slider